mRNA Expression of TP53 Attenuates Survival of HPV plus Locally Advanced Head and Neck Cancer

被引：0
|
作者：
Aneja, S. [1 ]
Contessa, J. N. [1 ]
Husain, Z. A. [1 ]
Glazer, P. M. [2 ]
Hansen, J. E. [2 ]
Bindra, R. S. [1 ]
Yu, J. B. [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Yale Univ, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.1440
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2871
引用
收藏
页码：E350 / E351
页数：2
相关论文
共 50 条
  • [41] TP53 genetic alterations in head-and-neck carcinomas from Brazil
    Nagai, MA
    Miracca, EC
    Yamamoto, L
    Moura, RP
    Simpson, AJG
    Kowalski, LP
    Brentani, RR
    INTERNATIONAL JOURNAL OF CANCER, 1998, 76 (01) : 13 - 18
  • [42] A prognostic model of head and neck cancer ties TP53 mutation to 3p loss
    Gross, Andrew M.
    Orosco, Ryan K.
    Shen, John P.
    Egloff, Ann Marie
    Carter, Hannah
    Hoffree, Matan
    Choueiri, Michel
    Coffey, Charles S.
    Lippman, Scott M.
    Hayes, David Neil
    Cohen, Ezra E.
    Grandis, Jennifer R.
    Nguyen, Quyen T.
    Ideker, Trey
    CANCER RESEARCH, 2014, 74 (19)
  • [43] Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
    Lyu, Haoyu
    Li, Mengyuan
    Jiang, Zehang
    Liu, Zhixian
    Wang, Xiaosheng
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2019, 17 : 1020 - 1030
  • [44] TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides
    Wooler, Gitte
    Melchior, Linea
    Ralfkiaer, Elisabeth
    Gjerdrum, Lise Mette Rahbek
    Gniadecki, Robert
    FRONTIERS IN MEDICINE, 2016, 3
  • [45] Characteristics and survival of patients with advanced cancer and TP53 mutations in phase I clinical trials
    Said, Rabih
    Ye, Yang
    Hong, David S.
    Janku, Filip
    Fu, Siqing
    Naing, Aung
    Wheler, Jennifer J.
    Kurzrock, Razelle
    Thomas, Christoforos
    Palmer, Gary A.
    Hess, Kenneth R.
    Wolff, Robert A.
    Tsimberidou, Apostolia Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] Alterations of the TP53 gene and TP53 protein expression in epithelial ovarian cancer before and after chemotherapy
    Okada M.
    Kigawa J.
    Minagawa Y.
    Kanamori Y.
    Itamochi H.
    Cheng X.
    Ohishi T.
    Terakawa N.
    International Journal of Clinical Oncology, 1998, 3 (4) : 240 - 246
  • [47] Mutations in exon 8 of TP53 are associated with shorter survival in patients with advanced lung cancer
    Liu, Yutao
    Xu, Fang
    Wang, Yubo
    Wu, Qingchen
    Wang, Buhai
    Yao, Yanwen
    Zhang, Yu
    Han-Zhang, Han
    Ye, Junyi
    Zhang, Lu
    Mao, Xinru
    Zhang, Zhe
    Liu, Jing
    Zhu, Liangjun
    Guo, Renhua
    ONCOLOGY LETTERS, 2019, 18 (03) : 3159 - 3169
  • [48] Chemoradiotherapy for locally advanced head and neck cancer
    Salama, Joseph K.
    Seiwert, Tanguy Y.
    Vokes, Everett E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (26) : 4118 - 4126
  • [49] Recurrence free survival in patients with HPV plus head and neck cancer treated with TORS and neck dissection
    Melachuri, Manasa
    Patel, Terral
    Awad, Daniel
    Kim, Seungwon
    Sridharan, Shaum
    Duvvuri, Umamaheswar
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Destructive-Type TP53 Mutations are Independently Associated With Worse Overall Survival in Patients With HPV-Negative Head and Neck Squamous Cell Carcinoma
    Dooley, S.
    Tobillo, R.
    de Joya, E.
    Freedman, L. M.
    Samuels, S.
    Sargi, Z. B.
    Weed, D.
    Perez, C.
    Samuels, M. A.
    Carmona, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E368 - E369
12345